The combination of curcumin and dasatinib exerts a synergistic inhibitory effect on the growth of CRC cells and intestinal adenomas of mice by inhibiting the activation of EGFR, IGF1R and c-Src [204]. The gene discussed is SRC; the disease is colorectal carcinoma.